DE60220642D1 - Perylenequinone zur anwendung mit immunotherapeutischen mitteln - Google Patents

Perylenequinone zur anwendung mit immunotherapeutischen mitteln

Info

Publication number
DE60220642D1
DE60220642D1 DE60220642T DE60220642T DE60220642D1 DE 60220642 D1 DE60220642 D1 DE 60220642D1 DE 60220642 T DE60220642 T DE 60220642T DE 60220642 T DE60220642 T DE 60220642T DE 60220642 D1 DE60220642 D1 DE 60220642D1
Authority
DE
Germany
Prior art keywords
compositions
present
methods
immunotherapeutic use
perylenequinone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60220642T
Other languages
English (en)
Other versions
DE60220642T2 (de
Inventor
Beatrice Leveugle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Quest Pharmatech Inc
Original Assignee
Altachem Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altachem Pharma Ltd filed Critical Altachem Pharma Ltd
Application granted granted Critical
Publication of DE60220642D1 publication Critical patent/DE60220642D1/de
Publication of DE60220642T2 publication Critical patent/DE60220642T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE60220642T 2001-01-30 2002-01-29 Perylenequinone zur anwendung mit immunotherapeutischen mitteln Expired - Lifetime DE60220642T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US26467701P 2001-01-30 2001-01-30
US264677P 2001-01-30
PCT/IB2002/000267 WO2002060482A2 (en) 2001-01-30 2002-01-29 Perylenequinones for use with immunotherapy agents

Publications (2)

Publication Number Publication Date
DE60220642D1 true DE60220642D1 (de) 2007-07-26
DE60220642T2 DE60220642T2 (de) 2008-02-21

Family

ID=23007123

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60220642T Expired - Lifetime DE60220642T2 (de) 2001-01-30 2002-01-29 Perylenequinone zur anwendung mit immunotherapeutischen mitteln

Country Status (9)

Country Link
US (1) US20040110846A1 (de)
EP (1) EP1357944B1 (de)
JP (1) JP2004529091A (de)
CN (1) CN1665535A (de)
AT (1) ATE364398T1 (de)
AU (1) AU2002234809B2 (de)
CA (1) CA2436233C (de)
DE (1) DE60220642T2 (de)
WO (1) WO2002060482A2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1349965A (zh) * 2000-10-25 2002-05-22 中国科学院感光化学研究所 带有脂肪环或芳香环的脂肪胺基取代去甲氧基竹红菌素及其合成方法和用途
US6627664B2 (en) * 2001-01-30 2003-09-30 Altachem Pharma Ltd. Perylenequinones for use as sonosensitizers
AU2004297235A1 (en) 2003-12-04 2005-06-23 Vertex Pharmaceuticals Incorporated Quinoxalines useful as inhibitors of protein kinases
US8506931B2 (en) * 2005-08-10 2013-08-13 Quest Pharmatech Inc. Perylenequinone derivatives and uses thereof
US8454991B2 (en) * 2006-07-24 2013-06-04 Quest Pharmatech Inc. Method and device for photodynamic therapy
CN102138640B (zh) * 2011-01-14 2012-12-05 江南大学 苝醌化合物在制备防治禽类病毒饲料中的应用
CN109456210B (zh) * 2017-09-06 2020-09-25 中国科学院理化技术研究所 一种竹红菌素迫位和2-位同时氨基取代的衍生物及其制备方法和应用
CN109453408A (zh) * 2018-11-16 2019-03-12 江南大学 抗菌创伤敷料及其制备方法
CA3135291A1 (en) * 2019-03-29 2020-10-08 The Brigham And Women's Hospital, Inc. Targeted synergistic cancer immunotherapy
CN115282133A (zh) * 2021-12-06 2022-11-04 温州医科大学 竹红菌乙素在制备抗结肠癌药物中的应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999065517A2 (en) * 1998-06-15 1999-12-23 Altarex Corp. Therapeutic compositions that produce an immune response by altering the antigen
JP2001508071A (ja) * 1997-01-10 2001-06-19 アルタレックス コーポレイション 光力学的治療で使用する置換ペリレンキノン
GB9710049D0 (en) * 1997-05-19 1997-07-09 Nycomed Imaging As Method
DK1009413T3 (da) * 1997-09-05 2007-06-11 Univ California Anvendelse af immunstimulerende oligonukleotider til forebyggelse eller behandling af astma
US20020022032A1 (en) * 1999-04-23 2002-02-21 Curry Patrick Mark Immuno-adjuvant PDT treatment of metastatic tumors
ATE290879T1 (de) * 1999-08-18 2005-04-15 Altarex Medical Corp Therapeutische antikörper gegen das muc-1 antigen und verfahren zu deren verwendung
AU5574001A (en) * 2000-04-25 2001-11-07 Immunex Corp Method for treatment of tumors using photodynamic therapy
US6627664B2 (en) * 2001-01-30 2003-09-30 Altachem Pharma Ltd. Perylenequinones for use as sonosensitizers
CA2437563C (en) * 2001-02-06 2010-03-23 Qlt Inc. Photodynamic therapy of occult age-related macular degeneration

Also Published As

Publication number Publication date
WO2002060482A3 (en) 2003-02-13
CN1665535A (zh) 2005-09-07
EP1357944A2 (de) 2003-11-05
DE60220642T2 (de) 2008-02-21
ATE364398T1 (de) 2007-07-15
WO2002060482A2 (en) 2002-08-08
AU2002234809B2 (en) 2005-04-07
CA2436233C (en) 2010-10-05
US20040110846A1 (en) 2004-06-10
JP2004529091A (ja) 2004-09-24
CA2436233A1 (en) 2002-08-08
EP1357944B1 (de) 2007-06-13

Similar Documents

Publication Publication Date Title
IL214325A (en) Antibody against cmet, a drug that includes and uses it
EP2481422A3 (de) Multiplex-Impfstoffe
FR20C1016I1 (de)
WO2004032829A3 (en) Immunostimulatory compositions and methods of stimulating an immune response
CR8231A (es) Anticuerpos rg1 y uso de los mismos
DE69942774D1 (de) Verwendung von bioadhaesiven und adjuvantien für die mukosale anwendung von antigenen
GEP20074091B (en) Cripto blocking antibodies and uses thereof
DK0710253T3 (da) Antistoffer, der er specifikke mod human prostatakirtel-kallikrein
ATE224184T1 (de) Verfahren zur mikroverkapselung von antigenen und verwendung der zusammensetzungen als impfstoffe
DE60007095D1 (de) Calanolide zur hemmung von btk
TW200640947A (en) Novel polypeptide ligands for toll-like receptor 2 (TLR2)
IS4518A (is) Nýtt lyfjaform fyrir bóluefni
MY150893A (en) Recombinant mva virus expressing dengue virus antigens, and the use thereof in vaccines
DK1163008T3 (da) Anvendelse af trehalose til stabilisering af en flydende vaccine
DE60220642D1 (de) Perylenequinone zur anwendung mit immunotherapeutischen mitteln
DE602006012328D1 (de) Bifunktionelle proteinanker
NO20023935L (no) Ny, ikke-antigen, mukosal adjuvansformulering som modulerer effektene av substanser inkludert vaksineantigener, i kontakt medmukosale kroppsoverflater
ATE275421T1 (de) Interleukin-12 und herpes simplex virusantigen enthaltende impfstoffe
ATE551069T1 (de) Mucin-fusionspolypeptid-vakzine, zusammensetzungen und ihre verwendung
DK1255845T3 (da) Modificerede cytokiner til anvendelse i cancerterapi
DK0845998T3 (da) Lægemidler til immunbehandling indeholdende antistoffer, der specifikt genkender MHCII-antigenet hos en patient, der skal behandles
GEP20053446B (en) Adjuvant Combination Formulations
ATE343375T1 (de) Impfstoff zur modulation zwischen t1 und t2 immunantworten
ATE386049T1 (de) Epstein-barr virus type b ctl epitopen
EP2292666A3 (de) Neoplasma-spezifische Antikörper und deren Verwendungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: QUEST PHARMATECH, INC., ALBERTA, CA